MV Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
MV Capital Management's ALNY Position: Q2 2026 in Review
MV Capital Management increased its Alnylam Pharmaceuticals (ALNY) stake by 3.1% in Q2 2026, buying an estimated $603 and bringing the position to 66 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #457.
MV Capital Management first reported a position in ALNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $29.2K in Q3 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- MV Capital Management held 66 shares of Alnylam Pharmaceuticals worth $19.9K as of Q2 2026.
- MV Capital Management bought 2 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $603.
- Alnylam Pharmaceuticals made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #457 holding.
- MV Capital Management first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
- MV Capital Management's Alnylam Pharmaceuticals position peaked at $29.2K in Q3 2025.
- 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.